5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Selected Advances in the Anti-arrhythmic Management of Atrial Fibrillation: 2023

      other
      , MD, FACC, FAHA, FHRS, FACP, FESC 1
      The Journal of Innovations in Cardiac Rhythm Management
      MediaSphere Medical
      Anti-arrhythmic drugs, anticoagulation, atrial fibrillation, catheter ablation, clinical trials, hybrid therapy, subclinical

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          OUP accepted manuscript

          (2020)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Early Rhythm-Control Therapy in Patients with Atrial Fibrillation

            Despite improvements in the management of atrial fibrillation, patients with this condition remain at increased risk for cardiovascular complications. It is unclear whether early rhythm-control therapy can reduce this risk.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation

              Catheter ablation is effective in restoring sinus rhythm in atrial fibrillation (AF), but its effects on long-term mortality and stroke risk are uncertain.
                Bookmark

                Author and article information

                Journal
                J Innov Card Rhythm Manag
                J Innov Card Rhythm Manag
                J Innov Cardiac Rhythm Manage
                JICRM
                The Journal of Innovations in Cardiac Rhythm Management
                MediaSphere Medical
                2156-3977
                2156-3993
                15 January 2024
                January 2024
                : 15
                : 1
                : 5728-5734
                Affiliations
                [1 ]Columbia University, New York, NY, USA
                Author notes
                Address correspondence to: James A. Reiffel, MD, c/o 202 Birkdale Lane, Jupiter, FL 33458, USA. Email: jar2@ 123456columbia.edu .

                In the past year, Dr. Reiffel has served as an investigator for J&J, Sanofi, Amarin, and InCarda Therapeutics and as a consultant for Sanofi and Acesion. No funding information was provided.

                Article
                icrm.2024.15014
                10.19102/icrm.2024.15014
                10829416
                38304092
                9ac07558-dfb0-4d99-8e32-e55e6219978a
                Copyright: © 2024 Innovations in Cardiac Rhythm Management

                This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).

                History
                Categories
                Expert Commentary

                anti-arrhythmic drugs,anticoagulation,atrial fibrillation,catheter ablation,clinical trials,hybrid therapy,subclinical

                Comments

                Comment on this article